McKinsey predicts a 7% annual growth in healthcare EBITDA, with specialty pharmacy driving revenue expansion. Technological advancements like AI offer efficiency and insights. Fresenius Medical Care AG shows promising growth potential in dialysis services, making it an undervalued healthcare stock.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing